AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Tacriva 0.03% Ointment

Prescription Icon
Prescription Required

Marketer

Rivan Pharma

Salt Composition

Tacrolimus (0.03% w/w)

Overview Tacriva 0.03% Ointment

Eczema (atopic dermatitis) is treated with Tacriva 0.03% Ointment, which reduces inflammation (skin redness and swelling) by modulating the activity of specific immune cells. This soothes itching and improves atopic dermatitis rashes. Apply Tacriva 0.03% Ointment externally, two to four times daily to affected areas, or as directed by your physician. Gently and evenly rub the ointment into the skin. Avoid overuse and do not bandage or cover treated skin. Consult your doctor if symptoms don't improve within two weeks or worsen. Common side effects may include erythema, headache, folliculitis, and application site reactions such as burning, irritation, itching, and redness. Use during pregnancy or breastfeeding is generally discouraged unless medically necessary.

Uses of Tacriva 0.03% Ointment

Managing atopic dermatitis

Major Benefits of Tacriva 0.03% Ointment:

Apply this medication topically only. Follow your physician's instructions regarding dosage and treatment length. Always refer to the product label for application details. Ensure the affected skin is clean and dry before gently rubbing in the ointment.

Common Side effects of Tacriva 0.03% Ointment:

  • Application site reactions (burning, irritation, itching and redness)
  • Headache
  • Hair follicle inflammation

How to use Tacriva 0.03% Ointment:

Apply this medication topically only. Follow your physician's instructions regarding dosage and treatment length. Always consult the product label for application guidelines. Ensure the affected skin is clean and dry before gently rubbing in the cream.

How Tacriva 0.03% Ointment works:

Immunosuppressant Tacriva 0.03% Ointment reduces skin inflammation's redness and swelling by inhibiting specific immune cells. This soothes itching and enhances rash improvement in atopic dermatitis.

SAFETY ADVICE

AlcoholAlcoholNone

No known drug interactions.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Tacriva 0.03% Ointment during pregnancy might pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible dangers before prescribing. Seek medical advice.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Application of Tacriva 0.03% Ointment while breastfeeding is likely safe. Available human data indicate minimal infant risk associated with the medication.

DrivingDrivingNone

No drug interaction identified.

KidneyKidneyNone

No drug interactions identified.

LiverLiverNone

No known drug interactions.

What if you forget to take Tacriva 0.03% Ointment :

Should you forget a Tacriva 0.03% Ointment application, use it promptly. Nevertheless, if your next scheduled application is imminent, omit the missed one and resume your usual dosing regimen.

Facts to Know About Tacriva 0.03% Ointment

LabelValue
Chemical Type Macrolide antibiotics
Developing Habits No.
Treatment Category Cancer Medications
Action Class Calcineurin inhibitor immunosuppressants

FAQs on Tacriva 0.03% Ointment

Tacriva 0.03% Ointment is an immune-modulating medicine that primarily reduces immune system activity. It treats moderate to severe eczema (atopic dermatitis) in adults whose condition is unresponsive to steroids or who experience steroid side effects. By targeting the overactive immune response responsible for the inflammation, itchiness, and dryness of atopic dermatitis, Tacriva 0.03% Ointment alleviates these symptoms.
Applying Tacriva 0.03% Ointment may cause mild to moderate skin irritation, including burning, itching, redness, warmth, pain, altered sensation, and rash at the application site. These usually subside within a week. Treatment also increases the risk of inflamed or infected hair follicles, cold sores, acne, and generalized herpes simplex infections.
Tacriva 0.03% Ointment offers safe and effective short-term relief from atopic dermatitis, demonstrating superior safety compared to other immunosuppressants. Minimal systemic absorption following topical application results in fewer side effects than oral treatments.
Tacriva 0.03% Ointment is not a controlled substance and does not have abuse potential. Controlled substances require authorization from both a doctor and regulatory authorities due to their potential for misuse.
Prolonged use of Tacriva 0.03% Ointment may increase the risk of lymphoma, a type of lymph node tumor. Limited studies indicate a potential link between Tacriva 0.03% Ointment, or similar medications, and the development of skin cancer or lymphoma. Consult your physician if Tacriva 0.03% Ointment is needed for over six weeks, or if your eczema symptoms worsen or fail to improve.
Tacriva 0.03% Ointment is a non-steroid medication that regulates the immune system. It treats eczema, particularly atopic dermatitis, without the skin thinning or other side effects associated with steroids.
Tacriva 0.03% Ointment
140
MRP 170
17% off